Related Experiment Video

Updated: Mar 25, 2026

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
08:15

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

692

Schizandrin A Inhibits Microglia-Mediated Neuroninflammation through Inhibiting TRAF6-NF-κB and Jak2-Stat3 Signaling

Fangjiao Song1, Kewu Zeng2, Lixi Liao2

  • 1Research Studio of Integration of Traditional and Western Medicine, First Hospital, Peking University, Beijing, 100034, China.

Plos One
|February 27, 2016
PubMed

Insights

Schizandrin A (Sch A) reduces neuroinflammation by inhibiting key inflammatory pathways in microglia. This compound shows promise for treating neurodegenerative diseases by protecting neurons from inflammatory damage.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Immunology

Background:

  • Microglia-driven neuroinflammation is central to neurodegenerative disease pathology.
  • Targeting microglial activation offers a therapeutic strategy for neurodegenerative disorders.

Purpose of the Study:

  • To investigate the neuroprotective effects of Schizandrin A (Sch A).
  • To elucidate the molecular mechanisms underlying Sch A's anti-inflammatory actions.

Main Methods:

  • Assessed Sch A's impact on nitric oxide (NO), tumor necrosis factor-alpha (TNF-α), and interleukin-6 (IL-6) production in BV-2 and primary microglia stimulated with lipopolysaccharide (LPS).
  • Evaluated neuroprotection in neurons exposed to microglia-conditioned medium.
  • Investigated molecular mechanisms including inducible nitric oxide synthase (iNOS), cyclooxygenase-2 (COX-2), TRAF6-IKKβ-NF-κB, and Jak2-Stat3 signaling pathways.

Main Results:

  • Sch A significantly reduced LPS-induced NO, TNF-α, and IL-6 production in microglia.
  • Sch A demonstrated neuroprotective effects against inflammatory injury.
  • Mechanistically, Sch A inhibited iNOS and COX-2 expression.
  • Sch A suppressed the LPS-induced activation of the TRAF6-IKKβ-NF-κB and Jak2-Stat3 pathways.

Conclusions:

  • Schizandrin A exhibits anti-inflammatory and neuroprotective properties.
  • Sch A alleviates microglia-mediated neuroinflammation by inhibiting the TRAF6-IKKβ-NF-κB and Jak2-Stat3 signaling pathways.
  • Sch A represents a potential therapeutic agent for neurodegenerative diseases.

More Related Videos

Author Spotlight: Insight Into Advances in Prion Diseases Research10:40

Author Spotlight: Insight Into Advances in Prion Diseases Research

Published on: August 11, 2023

886
Magnetic Isolation of Microglial Cells from Neonate Mouse for Primary Cell Cultures07:23

Magnetic Isolation of Microglial Cells from Neonate Mouse for Primary Cell Cultures

Published on: July 25, 2022

3.8K

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
13.8K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
10.3K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.9K